Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial Article Early Access

International Collaboration

cited authors

  • Gerstein, Hertzel C.; Mian, Rajibul; Ramasundarahettige, Chinthanie; Branch, Kelley R. H.; Del Prato, Stefano; Lam, Carolyn S. P.; Lopes, Renato D.; Pratley, Richard; Rosenstock, Julio; Sattar, Naveed

Publication Date

  • December 20, 2023

webpage

published in

category

keywords

  • GLP-1 analogue
  • cardiovascular disease
  • kidney disease
  • randomized trial
  • type 2 diabetes